Research Solutions, Inc. — Form 10-Q Summary
Reporting period: Fiscal second quarter and six months ended December 31, 2023. The interim financial statements are unaudited; amounts are in U.S. dollars.
Business context
Research Solutions provides cloud-based research software subscriptions (“Platforms”) and sources and delivers scientific, technical and medical articles (“Transactions”). During the period, it acquired ResoluteAI (July 2023) and Scite (December 2023), expanding its AI-enabled discovery and research tools.
Key financial metrics
| Metric | Three months ended Dec. 31, 2023 | Six months ended Dec. 31, 2023 | Prior-year comparable period |
|---|---|---|---|
| Revenue | $10.31 million | $20.37 million | $8.72 million; $17.40 million |
| Gross profit / margin | $4.48 million / 43.5% | $8.52 million / 41.8% | $3.40 million / 39.0%; $6.75 million / 38.8% |
| Operating loss | $420,000 | $1.52 million | $329,000; $150,000 |
| Net loss | $54,000 | $1.04 million | $256,000; $41,000 |
| Adjusted EBITDA (non-GAAP) | $318,000 | $(122,000) | $201,000; $635,000 |
| Operating cash flow | Not provided for the quarter | $(427,000) | $1.02 million for six months |
For the quarter, Platforms generated $3.13 million of revenue and Transactions $7.19 million. For the six-month period, those amounts were $5.73 million and $14.65 million, respectively.
Liquidity, debt and balance sheet
- Cash and cash equivalents were $2.70 million at December 31, 2023, down from $13.55 million at June 30, 2023. Investing cash outflow was $10.08 million, principally for the ResoluteAI and Scite acquisitions.
- Current assets were $11.62 million and current liabilities $16.71 million, a working-capital deficit of approximately $5.09 million. Deferred revenue, a current liability, was $7.84 million.
- No borrowings were outstanding under the revolving credit facility. The company reported approximately $2.43 million available, at a 9.5% rate, with maturity on February 28, 2024.
- Total liabilities were $25.50 million, including an $8.79 million contingent earnout liability. The company reported no off-balance-sheet arrangements.
Changes versus prior comparable periods
- Quarterly revenue increased 18.3%; six-month revenue increased 17.1%. Management attributed growth to customer deployments and expansion, acquisition-related Platform revenue, and higher paid article-order volume, including contribution from the FIZ asset purchase.
- Gross margin improved by 4.5 percentage points for the quarter and 3.0 points for six months. Management cited higher copyright margins on Transactions; Platform cost ratios increased, partly due to ResoluteAI hosting costs.
- Operating expenses rose 31.4% for the quarter and 45.4% for six months. Increases reflected acquired personnel, software development, legal and acquisition/proxy-related costs, higher amortization, and stock-based compensation.
- Quarterly net loss narrowed from $256,000 to $54,000, but six-month net loss widened from $41,000 to $1.04 million. Six-month Adjusted EBITDA fell from $635,000 to a loss of $122,000.
Outlook, risks and unusual items
- The filing provides no quantified revenue, earnings or cash-flow guidance. Management describes plans to develop additional Platform offerings using ResoluteAI and Scite technology.
- The lender identified covenant defaults relating to cash balances at SVB, deposit account control agreements and the adjusted quick ratio. Under a November 14, 2023 forbearance agreement, the lender agreed to forbear and waive existing defaults subject to regaining covenant compliance by January 30, 2024 and other conditions. The filing text does not clearly state whether those conditions were met; the credit facility’s February 28, 2024 maturity makes the status important to verify.
- ResoluteAI and Scite purchase-price allocations remained provisional at December 31, 2023. Scite consideration was approximately $20.9 million, including cash, stock and a contingent earnout; ResoluteAI consideration, net of cash acquired, was approximately $4.6 million. Acquisitions contributed materially to investing cash outflows, new intangible assets, goodwill and contingent liabilities.
- Other income was $376,000 for the quarter and $517,000 for six months; the filing text does not provide a clear breakdown here. The six-month cash-flow comparison also includes substantial noncash stock compensation adjustments.
- The company said inflation had not materially affected operations to date, but warned that future cost and interest-rate pressures could strain working capital. It reported no material changes to the risk factors in its FY2023 Form 10-K.
- Management concluded disclosure controls and procedures were effective at a reasonable assurance level as of December 31, 2023; no material change in internal control over financial reporting was reported during the quarter.
Important facts for investors to verify
- Whether the company met the lender’s January 30, 2024 forbearance conditions, and the resulting availability, terms or renewal of the credit facility.
- Cash runway and working-capital needs after the acquisitions, given the cash decline, operating cash outflow and current-liability position.
- Final purchase-price allocations and earnout amounts for ResoluteAI and Scite, and the acquired businesses’ contribution to revenue, margins and future cash generation.
- Whether Platform growth and improved Transaction margins can offset higher operating expenses and acquired-company costs.
- The source and sustainability of reported other income, and the continuing effect of stock-based compensation on reported earnings and dilution.